CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Novartis Pharmaceuticals Corporation v. Altaire Pharmaceuticals, Inc

1:08-cv-06009

Overview

Case Number 1:08-cv-06009
Filing Date 2008-07-01
Status Terminated
Termination Date 2009-12-29
Court District Court, S.D. New York (nysd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Altaire Pharmaceuticals, Inc Operating Company

Represented By

2 Attorneys Listed

Edward A. Meilman

Dickstein Shapiro LLP (NYC)

Fax: +1 (212) 997-9880

1633 Broadway, New York, NY 10019-6708

Dawn L. Rudenko

Dickstein Shapiro LLP (NYC)

Fax: +1 (212) 277-6501

1633 Broadway, New York, NY 10019-6708

Novartis Pharmaceuticals Corporation Operating Company

Represented By

3 Attorneys Listed

Jeffrey J. Oelke

White & Case LLP (NY)

Tel: +1 (212) 819-8200
Fax: +1 (212) 354-8113

1155 Avenue of the Americas, Suite 1444

James Stephen Trainor , Jr.

White & Case LLP (NY)

Tel: +1 (212) 819-8200
Fax: +1 (212) 354-8113

1155 Avenue of the Americas, Suite 1444

Amit Hasit Thakore

White & Case LLP (NY)

Tel: +1 (212) 819-8200
Fax: +1 (212) 354-8113

1155 Avenue of the Americas, Suite 1444

Court & Judges

Court

District Court, S.D. New York (nysd)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

No Co-Pending Disputes Detected in Current Index

There are no other active filings for this patent family across our indexed PTAB, U.S. Court, UPC, or EPO databases.

Patents Involved

No asserted patent numbers detected in initial docket filings yet.

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

8

Dispositive

7

Granted

3

Denied

0

Pending / Review

5

Motions by Category

Motion to Dismiss (FRCP 12(b)(6)) 2 Motion to Dismiss 4 Motion to Stay 1 Motion for Preliminary Injunction / TRO 1

Key Dispositive Motions & Rulings

Motion for Preliminary Injunction / TRO Pending / Under Review
ENDORSED LETTER addressed to Judge Loretta A. Preska from James Trainor dated 9/30/09 re: The parties request that the civil action remain open, pending dismiss...
Entry #28 • 2009-10-02 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
ENDORSED LETTER addressed to Judge Loretta A. Preska from Edward A. Meiman dated 2/27/2009 re: In light of the continuing settlement discussions, both parties r...
Entry #20 • 2009-02-27 Document →
Motion to Dismiss Pending / Under Review
REPLY /SurReply in Support of Plaintiff Novartis Pharmaceuticals Corporation's Opposition to Defendant Altaire Pharmaceuticals, Inc.'s Motion to Dismiss Pursuan...
Entry #17 • 2008-12-22 Document →
Motion to Dismiss Pending / Under Review
ENDORSED LETTER: addressed to Judge Loretta A. Preska from Dawn Rudenko dated 12/3/08 re: Counsel for defendants request leave to file under seal a reply in sup...
Entry #14 • 2008-12-05 Document →
Motion to Dismiss Granted
ORDER GRANTING PLAINTIFF'S REQUEST TO FILE ITS OPPOSITION TO DEFENDANT'S MOTION TO DISMISS UNDER SEAL: This Court, having considered Plaintiff Novartis Pharmace...
Entry #12 • 2008-11-24 Document →
Motion to Dismiss Pending / Under Review
ENDORSED LETTER addressed to Judge Loretta A. Preska from James Trainor dated 10/16/08 re: Counsel requests an extension of time to respond to defendants motion...
Entry #9 • 2008-10-17 Document →

Docket Entries

(31 total)
Pleading / Complaint

COMPLAINT against Altaire Pharmaceuticals, Inc. (Filing Fee $ 350.00, Receipt Number 656696)Document filed by Novartis Pharmaceuticals Corporation.(jfe) (sac). (Entered: 07/02/2008)

Entry #1 • 2008-07-01
1

RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Novartis Pharmaceuticals as a wholly-owned Corporation. Document filed by Novartis Pharmaceuticals Corporation.(jfe) (sac). (Entered: 07/02/2008)

Entry #2 • 2008-07-01
1
Pleading / Complaint

AFFIDAVIT OF SERVICE of Summons and Complaint. Altaire Pharmaceuticals, Inc served on 8/21/2008, answer due 9/10/2008. Service was accepted by Michael Sawaya, General Counsel. Document filed by Novartis Pharmaceuticals Corporation. (Trainor, James) (Entered: 08/29/2008)

Entry #3 • 2008-08-29
1
Court Order

STIPULATION AND ORDER that Altaire shall have until 10/10/08 to answer the complaint. Altaire Pharmaceuticals, Inc answer due 10/10/2008. (Signed by Judge Loretta A. Preska on 9/9/08) (cd) (Entered: 09/12/2008)

Entry #4 • 2008-09-12
1
Motion to Dismiss (FRCP 12(b)(6)) Granted

ORDER GRANTING DEFENDANT ALTAIRE PHARMACEUTICALS INC'S REQUEST TO FILE ITS MOTION TO DISMISS PURSUANT TO FRCP 12(B)(6) UNDER SEAL, defendant's motion is GRANTED, because the matters discussed disclose the terms of a confidential agreement between the parties. (Signed by Judge Loretta A. Preska on 10/10/08) (cd) (Entered: 10/10/2008)

Entry #5 • 2008-10-10
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc